RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY
SCOPUS
  • Year: 2021
  • Volume: 14
  • Issue: 1

Development and Validation of spectrophotometric estimation of vildagliptin through Oxidative coupling reaction using MBTH reagent in Pharmaceutical dosage form

  • Author:
  • Vaishali P. Patel*, Krishna A. Bhatt, Mrunali M. Shah, Dharti M. Patil, Rakshita S. Patel, Divya M. Desai, Prachi H. Parmar
  • Total Page Count: 5
  • Page Number: 62 to 66

Department of Quality Assurance, Parul Institute of Pharmacy and Research, Parul University, Waghodia Road-390019, Vadodara, Gujarat, India

*Corresponding Author E-mail: vp42468@gmail.com

Online published on 22 April, 2021.

Abstract

Scientifically estimation of Vildagliptin in bulk and pharmaceutical dosage forms by 3-methyl-2-bezothiazoline hydrazone reagent using longer wavelength give strong absorbance. The purpose of this analytical validation procedure is to validate using ICH guideline.3-methyl-2-bezothiazoline hydrazone reacts with ferric chloride in the presence of amine group, Resulting green coloured species scanned in uv-visible spectrophotometric with the range 400-800nm. Linearity concentration ranges10 to 50μg/ml and it given absorbance at 620nm, Correlation coefficient value 0.998, Recovery studies obtain within range of 98.41 to 99.75% at maximum absorbance 620nm. This method can be successfully applied for the estimation of drug content in pharmaceutical formulations. Resulting Analytical Validate method suitable for its intended use.

Keywords

3-methyl-2-benzothiazoline hydrazone, Vildagliptin, Ferric chloridespectrophotometric determination, ICH guidelines